• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABIOMED EUROPE GMBH IMPELLA CP; TEMPORARY CARDIAC SUPPORT BLOOD PUMP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABIOMED EUROPE GMBH IMPELLA CP; TEMPORARY CARDIAC SUPPORT BLOOD PUMP Back to Search Results
Model Number IMPELLA CP
Device Problems Difficult To Position (1467); Device Issue (2379); Patient-Device Incompatibility (2682)
Patient Problem Hemolysis (1886)
Event Date 08/15/2017
Event Type  malfunction  
Manufacturer Narrative
The impella cp pump and data logs were returned for analysis.The data log analysis confirmed the clinical report of the pump position being adjusted in relation to the valve.As the ifu states hemolysis is a "known potential adverse event" and furthermore: "evaluate the position of the impella® catheter if the automated impella® controller displays position alarms or if you observe lower than expected flows or signs of hemolysis.If the catheter does not appear to be correctly positioned, initiate steps to reposition it." the p-level changes, observed within the data logs, also coincide with the clinical report.The p-levels were decreased in an attempt to resolve hemolysis.Later the p-level was increased, while the pump was in proper position, and the hemolysis issues worsened, according to the clinical account, within hours.The p-level was again decreased and hemolysis issues reportedly resolved.The cp pump itself was analyzed, and nothing was identified on the pump that could have caused or contributed to the hemolysis.The pump was run through standard hemolysis testing procedures and passed.The reported failure was not reproduced.The lot of cp pumps was investigated in a manufacturing review.No other pumps have complaints leveled from the field for hemolysis.There is no corrective action as the root cause of the hemolysis could not be determined.The failure will continue to be monitored and trended.Internal reference (b)(4).
 
Event Description
On (b)(6) 2017 a (b)(6) year old male was taken to the emergency room after experiencing chest pain during a cat scan.He had a cardiac arrest in the er and was taken to the cardiac cath lab for care.The impella cp was placed for support due to the need for support during angioplasty to the left main, left anterior descending, and left circumflex coronary arteries.That evening, he was admitted to the icu for monitoring.Upon admission to the icu the patient's urine output began to change color and an echo was obtained to evaluate position in the left ventricle (lv) of the impella cp in relation to the valve.The standard blood draws were also hemolyzing at the time.The team did not take the advice of the abiomed representative, and re-adjust position of the impella.The following morning, the (b)(6), the position of the impella cp was adjusted from 1.4cm to 3.4cm.According the ifu of the impella cp: "positioning the inlet area of the catheter 3.5 cm below the aortic valve annulus and in the middle of the ventricular chamber, free from the mitral valve chordae." the patient was infused with 3 units of red blood cells after repositioning.The patient's hematocrit and hemoglobin were 8.9 and 24.2.Throughout the days of the (b)(6), the urine output and color were monitored.The color was still indicative of hemolysis.The patient was also placed on dialysis with his creatinine level being 6 mg/dl.Throughout the day of (b)(6) the team made adjustments to the pump's p level in attempted troubleshooting for the signs of hemolysis, although this did little to remedy the urine color change.Only with repositioning of the pump did the urine output improve.On the (b)(6) the urine color was clearing and impella weaning began.On the night of the (b)(6) the impella was explanted and the patient recovered without harm or injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPELLA CP
Type of Device
TEMPORARY CARDIAC SUPPORT BLOOD PUMP
Manufacturer (Section D)
ABIOMED EUROPE GMBH
neuenhofer weg 3
aachen, 52074
GM  52074
Manufacturer (Section G)
ABIOMED INC.
22 cherry hill drive
danvers MA 01923
Manufacturer Contact
ralph barisano
22 cherry hill drive
danvers, MA 01923
9786461400
MDR Report Key6866544
MDR Text Key86318722
Report Number1220648-2017-00067
Device Sequence Number1
Product Code OZD
UDI-Device Identifier00813502011258
UDI-Public00813502011258
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 08/15/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/14/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date04/30/2019
Device Model NumberIMPELLA CP
Device Catalogue Number0048-0020
Device Lot Number1285513
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/25/2017
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received08/15/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/02/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age71 YR
-
-